| Bioactivity | Z-LEHD-FMK TFA is a selective and irreversible inhibitor of caspase-9, protects against lethal reperfusion injury and attenuates apoptosis. Z-LEHD-FMK TFA exhibits the neuroprotective effect in a rat model of spinal cord trauma[1][2][3]. |
| Invitro | Z-LEHD-FMK (20 μM; pretreated for 30 min) completely protects HCT116 and 293 cells from TRAIL-induced toxicity[1].Z-LEHD-FMK (20 μM ; 6 h) protects normal human hepatocytes from TRAIL-induced apoptosis[1]. Apoptosis Analysis[1] Cell Line: |
| Name | Z-LEHD-FMK TFA |
| CAS | 524746-03-0 |
| Formula | C34H44F4N6O12 |
| Molar Mass | 804.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Z-LEHD-FMK TFA
CAS: 524746-03-0 F: C34H44F4N6O12 W: 804.74
Z-LEHD-FMK TFA is a selective and irreversible inhibitor of caspase-9, protects against lethal reperfusion injury and at
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.